UNSPSC 51161527: Ablukast

This classification denotes an anti-asthmatic agent with the molecular formula C28H34O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 000TKM5BBQ, chemically known as 2h-1-benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (+-)- but generally known as ablukast, which bears US NIH Compound Identifier 57109. Ablukast most often appears in sodium form.

UNSPSC 51161527 Ablukast, a Commodity code, covers pharmaceutical products — specifically asthma and allergy medications — procured by state and local health agencies, purchasing cooperatives, and institutional healthcare networks. Recent solicitations show state and local buyers acquiring generic ablukast formulations through cooperative purchasing agreements that aggregate demand across multiple jurisdictions and establish authorized distribution channels via pharmaceutical wholesalers. The work involves manufacturers or authorized distributors submitting detailed product specifications (National Drug Codes, SKUs, UPCs, strength, dosage form, packaging configurations) and committing to fixed or flexible pricing models, cGMP certification, and Drug Supply Chain Security Act compliance for multi-year terms.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, recently posted a Request for Proposal on January 20, 2026 seeking multiple vendors for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline. MMCAP coordinates purchasing across participating state and local government facilities, including Oregon, and requires approved vendors to maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with active chargeback systems and to provide products by May 15, 2026 for contracts effective July 1, 2026. Evaluation weights pricing competitiveness at 75 percent, fixed pricing at 10 percent, and compliance with administrative requirements, EDI capability, and fee structure at 5 percent each. Vendors must carry comprehensive insurance ($5 million general liability, $2 million network security and privacy liability, $2 million professional liability) and accept potential performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding timelines, or improper class-of-trade denials; no specific set-aside designations were identified in the solicitation materials.